IL18 and chronic kidney disease: Known kidney disease biomarkers associated with the AKI-to-CKD transition, such as HAVCR1 and IL-18, were associated with faster eGFR decline but showed smaller effect size (Supplemental Data File 1; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.195577DS1) (11).